..............page:591-596
Efficacy and Toxicity of Pemetrexed or Gemcitabine Combined with Cisplatin in the Treatment of Patients with Advanced Non-small Cell Lung Cancer
Xingsheng HU1; Shunchang JIAO2; Shucai ZHANG3; Zhehai WANG4; Mengzhao WANG5; Cheng HUANG6; Rongsheng ZHENG7; Kai LI8; Jie WANG9; Yajie WANG10; Xuenong OUYANG11; Wenguang LV12; Gang CHENG13; Chunhong HU14; Rongcheng LUO15; Yan SUN1 1Cancer Institute & Hospital; Chinese Academy of Medical Sciences; Beijing 100021; China; 2Chinese PLA General Hospital; Beijing 100853; China; 3Beijing Chest Hospital; Capital Medical University; Beijing 100095; China; 4Shandong Provincial Cancer Hospital; Jinan 250117; China; 5Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing 100730; China; 6Fujian Provincial Cancer Hospital; Fuzhou 350014; China; 7First Affiliated Hospital of Bengbu Medical College; Bengbu 233000; China; 8Tianjin Cancer Hospital; Tianjin 300060; China; 9Beijing Cancer Hospital; Beijing 100142; China; 10Changhai Hospital; Shanghai 200433; China; 11Fuzhou General Hospital of Nanjing Military Command; Fuzhou 350025; China; 12Nankai University Affiliated Hospital; Tianjin 300191; China; 13Beijing Hospital; Beijing 100730; China; 14The Second Xiangya Hospital of Central South University; Changsha 410001; China; 15Nanfang Hospital; Guangzhou 510515; China
..............page:569-575
A Randomized, Controlled, Multicenter Clinical Trial Comparing Pemetrexed/Cisplatin and Gemcitabine/Cisplatin as First-line Treatment for Advanced Nonsquamous Non-small Cell Lung Cancer
Yan HUANG1;2; Yunpeng LIU3; Jianying ZHOU4; Nong XU5; Baolan LI6; Gang WU7; Jian FANG8; Kai LI9; Xiaoqing LIU10; Wei LIU11; You LU12; Mengzhao WANG13; Wenchao LIU14; Houjie LIANG15; Yiping ZHANG16; Cheng HUANG17; Shunjin WANG18; Yajie WANG19; Shiying YU20; Jianhua CHANG21; Zhehai WANG22; Zhihuang HU1;2; Li ZHANG1;2 1Department of Medical Oncology; Sun Yat-sen University Cancer Center; 510060 Guangzhou; China; 2State Key Laboratory of Oncology in South China; 510060 Guangzhou; China; 3Department of Medical Oncology; First Hospital of China Medical University; 110001 Shenyang; China; 4Department of Respiratory Diseases; First Affiliated Hospital of Medical School of Zhejiang University; 310003 Hangzhou; China; 5Department of Chemotherapy; the First Affiliated Hospital of Medical School of Zhejiang University; 310003 Hangzhou; China; 6Department of General Medicine; Beijing Chest Hospital; Capital Medical Hospital; 101149 Beijing; China; 7Tumor Center; Union Hospital; Tongji Medical College; Huazhong University of Science and Technology; 430022 Wuhan; China; 8Department of Thoracic Medical Oncology; Peking University School of Oncology; Beijing Cancer Hospital and Institute; 100142 Beijing; China; 9Department of Thoracic Medical Oncology; Tianjin Medical University Cancer Institute and Hospital; 300060 Tianjin; China; 10Department of Thoracic Medical Oncology; Affiliated Hospital of Academy of Military Medical Sciences; 100071 Beijing; China; 11Department of Medical Oncology; Hebei Medical University Fourth Hospital; 050011 Shijiazhuang; China; 12Department of Thoracic oncology; West China Hospital; West China School of Medicine Sichuan University; 610041 Chengdu; China; 13Department of Respiratory Diseases; Peking Union Medical College Hospital; Peking Union Medical College and Chinese Academy of Medical Science; 100730 Beijing; China; 14Department of Oncology; Xijing Hospital; Fourth Military Medical University; 710032 Xi’an; China; 15Department of Oncology; First Affiliated Hospital; Third Military Medical University; 400038 Chongqing; China; 16Department of Medical Oncology; Zhejiang Cancer Hospital; 310022 Hangzhou; China; 17Department of Thoracic Oncology; Fujian Provincial Cancer Hospital; 350014 Fuzhou; China; 18Department of Oncology; Second Affiliated Hospital of Nanchang University; 330006 Nanchang; China; 19Department of Oncology; Changhai Hospital of Shanghai; Second Military Medical University; 200433 Shanghai; China; 20Cancer Center; Tongji Hospital; Tongji Medical College; Huazhong University of Science and Technology; 430030 Wuhan; China; 21Department of Medical Oncology; Fudan University Shanghai Cancer Center; 200032 Shanghai; China; 22Department of Medical Oncology; Shandong Cancer Hospital; 250117 Jinan; China
..............page:576-582
..............page:602-605
..............page:597-601
..............page:583-590
..............page:612-618
..............page:619-620
Review on Immunotherapies for Lung Cancer
Sha JIN1; Jianhui TIAN2 1Graduate Student of Shanghai University of Traditional Chinese Medicine; Shanghai 201203; China; 2Department of Oncology; Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine; Shanghai 200032; China
..............page:606-611
In Vitro Toxicity of Naturally Occurring Silica Nanoparticles in C1 Coal in Bronchial Epithelial Cells
Guangjian LI1;Yunchao HUANG1;Yongjun LIU2;Lv GUO3;Yongchun ZHOU4;Kun YANG5;Ying CHEN1;Guangqiang ZHAO1;Yujie LEI1 1Department of Cardiothoracic Surgery;the Third Affiliated Hospital of Kunming Medical University/the Tumor Hospital of Yunnan Province;Kunming 650118;China;2Advanced Analysis and Measurement Center of Yunnan University;Kunming 650091;China;3The Technical Department of Kunming Sino-Platinum Metals Catalyst Co.Ltd.;Kunming 650106;China;4The Third Affiliated Hospital of Kunming Medical University/The Research Institute of Tumor Kunming 650118;China;5The department of Anesthesiology of the First Affiliated Hospital of Kunming Medical University;Kunming 650032;China
..............page:561-568